7456 Federal Register / Vol. 87, No. 27 / Wednesday, February 9, 2022 / Notices 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Form name Number of 

respondents 

Total 

burden hours 

Average 

hourly 

wage rate 

Total 

cost burden 

Setting Demographics Survey ......................................................................... 9 2.25 a $57.12 $128.52 

TeamSTEPPS® Team Assessment Tool for Improving Diagnosis ................. 265 66.25 b 103.06 6,827.73 

TeamSTEPPS® Team Assessment Tool for Improving Diagnosis ................. 85 21.25 c 15.50 329.38 

Total .......................................................................................................... 359 89.75 ........................ $7,285.63 

aBased on the mean wages for Medical and Health Services Managers (Code 11–9111). bBased on the mean wages for Family Medicine Physicians (Code 29–1215). cBased on the mean wages for HC Support Occupations (Code 31–0000). 

Occupational Employment Statistics, May 2020 National Occupational Employment and Wage Estimates United States, U.S. Department of 

Labor, Bureau of Labor Statistics. https://www.bls.gov/oes/current/oes_nat.htm#b29-0000. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, 44 U.S.C. 3501–3520, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) Whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ’s health care research and health 

care information dissemination 

functions, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection(s) of 

information; (c) ways to enhance the 

quality, utility and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: February 4, 2022. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2022–02734 Filed 2–8–22; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—SIP22–002, 

Electronic Health Record Study to Examine 

Factors and Diagnostic Pathways that 

Facilitate Early Ovarian Cancer Diagnoses. 

Date: April 27, 2022. 

Time: 11:00 a.m.–6:00 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Jaya 

Raman, Ph.D., Scientific Review Officer, 

National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 4770 

Buford Highway, Mailstop S107–B, Atlanta, 

Georgia 30341, Telephone: (770) 488–6511, 

Email: JRaman@cdc.gov. 

The Director, Strategic Business Initiatives 

Unit, Office of the Chief Operating Officer, 

Centers for Disease Control and Prevention, 

has been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–02647 Filed 2–8–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—SIP22–003, 

Improving and evaluating measures to 

identify tics and tic disorders including 

Tourette syndrome in children in 

epidemiologic studies and clinical settings. 

Date: April 28, 2022. 

Time: 11:00 a.m.–6:00 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Jaya 

Raman, Ph.D., Scientific Review Officer, 

National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 4770 

Buford Highway, Mailstop S107–B, Atlanta, 

Georgia 30341, Telephone: (770) 488–6511, 

Email: JRaman@cdc.gov. 

The Director, Strategic Business Initiatives 

Unit, Office of the Chief Operating Officer, 

Centers for Disease Control and Prevention, 

has been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 


lotter on DSK11XQN23PROD with NOTICES1